12100 West 6th Ave. Lakewood, CO 80228 303.565.2724monitoring@mesalabs.com
FacebookTwitterYouTubeLinkedinWebsite
Mesa Labs
Mesa Labs
Continuous Monitoring Solutions
  • Equipment
    • VP Connect
    • ViewPoint VPx Sensor
    • Infitrak Sensors
  • Systems
    • ViewPoint Monitoring System
    • FreshLoc Temperature Monitoring System
    • Infitrak Transport Monitoring
    • CheckPoint
    • AmegaView
    • Temperature Mapping
    • Cold Chain Service
    • Other Mesa Products
  • Industries
    • Blood Banks
    • Pharmacy
    • Biotechnology
    • Hospitals
    • Forensic Labs
    • Pharmaceuticals
    • IVF Labs
    • Hospital Food & Nutrition
    • Life Sciences
    • Repositories
    • Food Manufacturing
    • Colleges/Universities
    • Military
  • Documents & Resources
    • Documents & Manuals
    • Videos
    • Certifications
    • Mesa Monitor Newsletter
    • Related Links
    • Blog
    • FAQs
  • Software
  • Contact
    • Contact Us
    • Technical Support
 
  • Equipment
    • VP Connect
    • ViewPoint VPx Sensor
    • Infitrak Sensors
  • Systems
    • ViewPoint Monitoring System
    • FreshLoc Temperature Monitoring System
    • Infitrak Transport Monitoring
    • CheckPoint
    • AmegaView
    • Temperature Mapping
    • Cold Chain Service
    • Other Mesa Products
  • Industries
    • Blood Banks
    • Pharmacy
    • Biotechnology
    • Hospitals
    • Forensic Labs
    • Pharmaceuticals
    • IVF Labs
    • Hospital Food & Nutrition
    • Life Sciences
    • Repositories
    • Food Manufacturing
    • Colleges/Universities
    • Military
  • Documents & Resources
    • Documents & Manuals
    • Videos
    • Certifications
    • Mesa Monitor Newsletter
    • Related Links
    • Blog
    • FAQs
  • Software
  • Contact
    • Contact Us
    • Technical Support

FDA Inspections

October 14, 2015Continuous Monitoring BlogBy Lorrie Switzer

If your company holds a 510(k) on a device, the FDA may perform an inspection of your facility for any number of reasons including routinely scheduled investigations or response to a reported problem.  These inspections are supposed to happen at least once every two years.  There is no requirement, though, for the FDA to give you prior notice of their intent to visit your facility.

When an investigator does show up, they are required to present you with an FDA form 482 (Notice of Inspection) along with their credentials.  Upon their arrival, the appropriate person(s) within your company should be immediately contacted (quality assurance manager, production manager, area director, etc), and the inspector should be accompanied by at least one of these people at all times.

The inspector will typically want to evaluate your production process, review specific related records, interview employees and collect samples.  For example, they may want to know who performed different aspects of production, how authority is delegated, how and where data is recorded, how staff has been trained, whether or not product was manufactured in compliance with procedures and whether record retention requirements are upheld.  The investigator is not allowed to ask for access to personnel data, other than training records.  Financial statements, sales data, pricing information and research records are also not to be shared with inspectors.

To prepare for an FDA visit, it is suggested to read the FDA document “Investigations Operations Manual (IOM)”.  This guidance document was created for the FDA inspectors to follow.  Generally, the inspector is looking to verify that your company is following cGMP, your staff is familiar with regulations and that there is documentation available to provide proof of compliance regarding training and monitoring.  The FDA will also audit any process validation protocols, along with data and information related to the 510(k) registered device(s).

Upon conclusion of their inspection, the investigator will need to meet with your management team to discuss any significant findings and concerns.  A written report will be given to the management team, which will include a summary of any objectionable conditions (also known as a form 483).

Let’s talk monitoring!

Talk with one of our experts to get your questions answered and see how we can help you solve your continuous monitoring pain points.


blood banksGovernment / MilitaryHospitalsLaboratoriesMilitaryPharmaceutical
About the author

Lorrie Switzer

Lorrie Switzer is the Continuous Improvement Manager for Mesa’s biological indicator manufacturing facilities in Omaha, NE and Bozeman, MT. Since joining the company in 2010 (as a temporary employee in Assembly & Packaging), she has worked her way through various positions in the Quality Assurance department, ultimately helping to create her existing position. Lorrie holds a B.S. in International Business from Teikyo Post University.

Related posts
Visit our Experts!
Tradeshow Season is Upon Us
April 10, 2018
FreshLoc Monitoring
FreshLoc Environmental Monitoring System
March 15, 2018
Donate Frequently!
Donating Blood is More Helpful When Done Regularly
November 9, 2017
ViewPoint Monitoring System for Blood Banks
October 12, 2017
Visit Booth #105
Visit us at the HCP Fall Hospital Pharmacy Conference!
October 5, 2017
Visit booth 1618
Visit us at the 2017 AABB Annual Meeting!
September 28, 2017
Have Questions?

Contact Us!

Sign up for our Newsletter!
Stay up to date on industry news, new products and product updates with our Mesa Monitor newsletter

Featured Articles
  • 5 Questions & Answers
    5 Questions You Must Answer to Choose the Ideal PCM
    May 16, 2017
  • Top 5 Ways to Solve Manual Temperature Monitoring Challenges
    August 7, 2017
  • A Case Study
    Cellular Dynamics International; a Case Study
    September 5, 2017
About Us
  • About Mesa Labs
  • Newsletter
  • Upcoming Events
  • Certifications
  • Corporate Site
  • Privacy Policy
  • Terms & Conditions
Contact
Mesa Laboratories, Inc.
12100 West 6th Ave.
Lakewood, CO 80228

303.565.2724
monitoring@mesalabs.com

Find us on:

FacebookTwitterYouTubeLinkedinWebsite
© 2016 Mesa Labs, Inc. All rights reserved.